medigraphic.com
ISSN 0016-3813 (Print)

2013, Number 6

<< Back Next >>

Gac Med Mex 2013; 149 (6)

Metastatic oropharyngeal squamous cell carcinoma in cervical lymph nodes associated to HPV infection type 16 and 45; clinical, morphological and molecular study of two cases

Soria-Céspedes D, Canchola AG, Lara-Torres CO, Sánchez-Marle JF, Hernández-Peña RE, Ortiz-Hidalgo C

Language: Spanish
References: 27
Page: 673-679
PDF size: 431.20 Kb.


ABSTRACT

Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma has been identified as a distinct entity within squamous cell carcinoma of the head and neck. In contrast to carcinomas associated with alcohol and/or tobacco, this subtype occurs at younger age, with frequent absence of classic risk factors, correlation with oral sexual habits, strong predilection for the palatial tonsils and the base of the tongue (lingual tonsils), basaloid or lymphoepithelial differentiation, higher degree of radiosensitivity, and overall better survival. We report two cases of lymph node, metastatic, poorly differentiated squamous cell carcinoma that were positive by immunohistochemistry for p16 with detection of HPV-16 and HPV-45 by PCR.


REFERENCES

  1. Zengel P, Assmann G, Mollenhauer M, et al. Cancer of unknown primary originating from oropharyngeal carcinomas are strongly correlated to HPV positivity. Virchows Arch. 2012;461:283-90.

  2. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758-62.

  3. McHugh JB. Association of cystic neck metastases and human papillomavirus- positive oropharingeal squamous cell carcinoma. Arch Pathol Lab Med. 2009;133:1798-803.

  4. Gallegos-Hernández JF, Paredes-Hernández E, Flores-Díaz R, Minauro- Muñoz G, Apresa-García T, Hernández-Hernández DM. Virus del papiloma humano asociado con cáncer de cabeza y cuello. Cir Cir. 2007;75:151-5.

  5. Dirección General de Epidemiología. Registro histopatológico de cáncer. México: Secretaría de Salud; 2002.

  6. Tachezy R, Klozar J, Saláková M, et al. HPV and other risk factors of oral cavity/ oropharingeal cancer in the Czech Republic. Oral Diseases. 2005;11:181-5.

  7. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009;119:1542-9.

  8. Hocking JS, Stein A, Conway EL, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharingeal cancers. Br J Cancer. 2011;104:886-91.

  9. Ernster JA, Sciotto CG, O´Brien MM, Robinson LJ, Willson T. Prevalence of oncogenic human papillomavirus 16 and 18 in the palatine tonsils of the general adult population. Arch Otolaryngol Head Neck Surg. 2009;135:554-7.

  10. Anantharaman D, Gheit T, Waterboer T, et al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst. 2013;105(8):536-45.

  11. Kreimer AR, Chaturvedi AK. HPV-associated oropharingeal cancers-are they preventable? Cancer Prev Res. 2011;4:1346-9.

  12. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008;30:898-903.

  13. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human Papillomavirus and rising oropharingeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301.

  14. Löning T, Ikenberg H, Becker J, et al. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol. 1985;84:417-20.

  15. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg. 1989;115:621-5.

  16. Micheau C, Cachin Y, Caillou B. Cystic metastases in the neck revealing occult carcinoma of the tonsil. A report of six cases. Cancer. 1974;33:228-33.

  17. Syrjänen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004;57:449-55.

  18. Sisk J, Schweinfurth JM, Wang XT, Chong K. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope. 2006;116:1372-4.

  19. Chen R, Cehr P, Waterboer T, et al. Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol. 2005;43:1408-10.

  20. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-75.

  21. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF. Establishment of human papilloma virus infection requires cell cycle progression. PLoS Pathog. 2009;5:e1000318.

  22. Hwang ES, Nottoli T, Dimaio D. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. Virology. 1995;211:227-33.

  23. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129-36.

  24. Huh K, Zhou X, Hayakawa H, et al. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol. 2007;81:9737-47.

  25. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-9.

  26. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009;119:1542-9.

  27. Flores-de la Torre C, Hernández-Hernández DM, Gallegos- Hernández JF. El virus de papiloma huma como factor pronóstico en pacientes con carcinoma epidermoide de cabeza y cuello. Cir Cir. 2010;78:221-8.




2020     |     www.medigraphic.com